Aditxt, Inc. Debt Conversion, Original Debt, Amount
Aditxt, Inc. (ADTX) reported Debt Conversion, Original Debt, Amount of $1.58 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2026-03-31
- Aditxt, Inc. debt conversion, original debt, amount for the quarter ending 2024-12-31 was $0.00.
- Aditxt, Inc. debt conversion, original debt, amount for the quarter ending 2024-09-30 was $913.71K.
- Aditxt, Inc. debt conversion, original debt, amount for fiscal 2024 was $1.58M.
| Period end | Debt Conversion, Original Debt, Amount 3 month | Debt Conversion, Original Debt, Amount 6 month | Debt Conversion, Original Debt, Amount 9 month | Debt Conversion, Original Debt, Amount 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $913.71K derived: sum of 2 quarters · filed 2026-03-31 | $1.58M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $913.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-18 | $1.58M 10-Q · filed 2025-11-18 | ||
| 2024-06-30 | $662.72K 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |